01Mar 2025
JAK Inhibitors vs. Biologics: Pain Reduction in Rheumatoid Arthritis

JAK Inhibitors vs. Biologics: Pain Reduction in Rheumatoid Arthritis

The retrospective study analyzed data from 11,387 Swedish rheumatoid arthritis patients. JAK inhibitors showed a greater pain decrease at 3 months (4.0 mm more than TNFis) and higher rates of low pain at 12 months, especially in those previously treated with two or more bDMARDs. JAKs are demonstrated at least similar pain relief compared to non-TNFi biologics, suggesting a promising alternative for RA pain management.

  • #rheumatology

Like

Save

Share